title: Infections and Psoriasis Treatment: More "Real-World" Data Needed with Critical Appraisal.
abstract: Data from the Spanish registry BIOBADADERM suggest that the risks of any infectious episode in patients treated with biologics are limited, not exceeding the risks observed with a conventional treatment such as cyclosporine. The registry lacked enough statistical power to analyze risks for severe infections. These should be the focus of further research, although the difficulties of "real-world" data analysis should not be trivialized.
authors.affiliation: Study Center of the Italian Group for Epidemiologic Research in Dermatology (GISED), Department of Dermatology, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy. Electronic address: luigi.naldi@gised.it.
authors.forename: Luigi
authors.initials: L
authors.lastname: Naldi
mesh_terms: D001688:Biological Products; D016572:Cyclosporine; D006801:Humans; D011565:Psoriasis; D012042:Registries
chemical_list: D001688:Biological Products; D016572:Cyclosporine